Court of Appeals for the Federal Circuit June 10, 2009, 2008-1600 (Ortho-McNeil Pharmaceutical, Inc. v. Mylan Laboratories Inc.)
Also known as
United States · · · 10-06-2009
United States Court of Appeals for the Federal Circuit
2008-1600
ORTHO-MCNEIL PHARMACEUTICAL, INC.
and JOHNSON & JOHNSON PHARMACEUTICAL
RESEARCH AND DEVELOPMENT, LLC,
Plaintiffs,
and
DAIICHI PHARMACEUTICAL CO., LTD.,
Plaintiff-Appellee,
v.
MYLAN LABORATORIES INC.
and MYLAN PHARMACEUTICALS INC.,
Defendants-Appellants.
Mark Boland, Sughrue Mion, PLLC, of Washington, DC, argued for plaintiff-
appellee. With him on the brief were Brett S. Sylvester and Michael R. Dzwonczyk. Of
counsel on the brief were Henry B. Gutman, Robert A. Bourque and Noah M. Leibowitz,
Simpson Thacher & Bartlett, LLP, of New York, New York.
James H. Wallace, Jr., Wiley Rein LLP, of Washington, DC, argued for defendants-
appellants. With him on the brief were Kevin P. Anderson, Robert J. Scheffel and Brian H.
Pandya.
Appealed from: United States District Court for the Northern District of West Virginia
Judge Irene M. Keeley
United States Court of Appeals for the Federal Circuit
2008-1600
ORTHO-MCNEIL PHARMACEUTICAL, INC.
and JOHNSON & JOHNSON PHARMACEUTICAL
RESEARCH AND DEVELOPMENT, LLC,
Plaintiffs,
and
DAIICHI PHARMACEUTICAL CO., LTD.,
Plaintiff-Appellee,
v.
MYLAN LABORATORIES INC.
and MYLAN PHARMACEUTICALS INC.,
Defendants-Appellants.
Appeal from the United States District Court for the Northern District of West
Virginia in case no. 1:02-CV-32, Judge Irene M. Keeley.
___________________________
DECIDED: June 10, 2009
___________________________
Before MAYER, DYK, and MOORE, Circuit Judges.
DYK, Circuit Judge.
Defendants-Appellants Mylan Laboratories and Mylan Pharmaceuticals
(collectively “Mylan”) appeal from the district court’s order awarding approximately $1.3
million in costs to Plaintiff-Appellee Daiichi Pharmaceutical Co. (“Daiichi”) under
28 U.S.C. § 1920 and Federal Rule of Civil Procedure 54(d). We affirm-in-part, vacate-
in-part, and remand.
BACKGROUND
This appeal concerns an award of costs stemming from a patent dispute. Daiichi
is the owner of U.S. Patent No.
Read the full text
This document is published by courtlistener.com.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit